Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2012 | 02:16am CET

Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement

XIANYANG, China, April 20, 2012/PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in Chinafor a variety of diseases and conditions, today announced that it has received written notification from the Nasdaq Listing Qualifications department that it has regained compliance with the minimum bid price requirement of $1.00per share for continued listing of its common stock on The NASDAQ Global Market set forth in Nasdaq Listing Rule 5450(a)(1), as its common shares achieved a closing bid price of $1.00or more for 10 consecutive business days prior to the compliance deadline of April 23, 2012and this matter is now closed.

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit: http://www.biostarpharmaceuticals.com

Safe Harbor relating to the Forward-Looking Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company uses words and phrases such as "guidance," "forecasted," "projects," "is expected," "remain confident," "will" and similar expressions to identify forward-looking statements in this press release, including forward-looking statements. Undue reliance should not be placed on forward-looking information. Forward-looking information is based on current expectations, estimates and projections that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Biostar and described in the forward-looking information contained in this news release. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the Company's ability to maintain its ongoing compliance with the Nasdaq continued listing requirements, success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, its ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, its ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our most recent Annual Report on Form 10-K for the year ended December 31, 2011, and other subsequent filings. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

For more information contact:




BioStar Pharmaceuticals, Inc. 

The Equity Group, Inc.

Zack Pan, CFO 

Lena Cati

Tel: 405-996-8829 

Tel: 212 836-9611

Email: zpan@aoxing-group.com

Email: lcati@equityny.com

SOURCE Biostar Pharmaceuticals, Inc.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
03:24p KOHL : Students get shopping spree with cops
03:24p THYSSENKRUPP : Secrets stolen in cyber attack on German firm making Israeli subs
03:24p AMERICAN VANGUARD : Posters promoting white supremacist, neo-Nazi organization found at Emerson College
03:24p PARAGON SOFTWARE SYSTEMS : Wins Green Supply Chain Award
03:23p GRIFFIN INDUSTRIAL REALTY : Announces Fiscal 2016 Fourth Quarter Leasing
03:22p FUNCTION(X) INC. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events (form 8-K)
03:22p ECB to scale back asset buys as it extends to end-2017
03:22p REAL GOODS SOLAR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
03:21p SAMPO PLC : Managers' Transactions (Magnusson)
03:21p SAMPO PLC : Managers' Transactions (Wennerklint)
Latest news
Advertisement
Hot News 
-23.08%NOVAE : shares slump after insurer warns on FY underwriting contributions
-9.31%Outsourcer Capita cuts 2016 profit forecast again, to sell assets
-5.56%SPORTS DIRECT INTERNATIONAL : warns tough times ahead after Brexit knocks profit
4.53%EFG INTERNATIONAL : says to cut up to 450 jobs in BSI integration
-4.82%AIXTRON : Germany says takes note of withdrawal of takeover offer for Aixtron
Most Read News
04:17a EXCLUSIVE : Edmond de Rothschild to close Hong Kong operations - sources
12/07 HYUNDAI MOTOR : S.Korea worries about growing economic risks, amid impeachment push for President Park
08:44a VOLKSWAGEN : EU takes legal action against Germany, UK over Volkswagen scandal
12/07 MEDTRONIC : China says fines Medtronic local unit 118.5 million yuan for price fixing
12/07 Retailer Wal-Mart de Mexico to invest $1.3 billion in Mexico
Most recommended articles
12/02 Platts considers first addition to Brent basket since 2007
09:20a Germany's highest court to rule on nuclear fuel tax in 2017
09:08a UniCredit sells Polish assets ahead of share issue
08:55a AIXTRON : China's Fujian drops Aixtron bid after Obama blocks deal
08:52a TELEFONAKTIEBOLAGET LM ERICSSON : Ericsson says Swedish staff cuts running ahead of plan